Fabry Disease Treatment Market by Type, Application, Element - Global Trends and Forecast to 2030
Global Market Insights recently introduced report on Global Fabry Disease Treatment Market Report is an in-depth study providing complete analysis of the industry for the period 2022 to 2030. It provides complete overview of Global Fabry Disease Treatment industry considering all the major industry trends, market dynamics and competitive scenario.
Patients with rare genetic diseases are facing a challenging path to proper diagnosis due to low disease awareness. To reduce barriers to comprehensive testing methods, several projects have been developed worldwide. For example, Sanofi Genzyme and PerkinElmer Genomics launched the Lantern Project to facilitate the screening of suspected Fabry and other disorders, which is anticipated to contribute to market expansion over the projected timeframe.
Browse key industry insights spread across 109 pages with 123 market data tables & 17 figures & charts from the report, “Fabry Disease Treatment Market Size By Treatment Type (Enzyme Replacement Therapy (ERT) {By Drug Type (Agalsidase Alpha, Agalsidase Beta}, By End-use (Physician Office and Home Settings)}, Chaperone Therapy), By Industry Analysis Report, Price Trends, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/fabry-disease-treatment-market
The Fabry disease treatment industry is bifurcated in terms of treatment type and regional landscape.
Based on the treatment type, the market is segregated into chaperone therapy and enzyme replacement therapy (ERT). Among these, the chaperone therapy segment is set to account for a considerable market share by 2030. This is attributed to the capability of small-molecule chaperones to bind to active sites of mutant forms of the alpha-galactosidase A enzyme, stabilize them, and restore the function of the natural enzyme.
The binding and stabilization can help facilitate the proper trafficking of alpha-Gal A to the lysosomes, enabling the restoration of enzymatic activity of the mutant protein and lowering the rate of accumulation of glycolipids in organ cells. These benefits will likely encourage healthcare professionals to rely on chaperone therapy for Fabry disease diagnosis and in turn, drive the segmental expansion.
On the regional front, the Europe Fabry disease treatment industry is expected to register considerable revenue by 2030. This can be credited to the rising adult population and the potential increase in the prevalence of late-onset Fabry disease symptoms. According to data from Eurostat, the number of people aged 80 years and above is likely to grow by two and a half times between 2021 and 2100. Since elderly people are at higher risk of Fabry disease, this population rise may assert a positive influence on regional market trends.
Likewise, the Asia Pacific is also anticipated to emerge as a lucrative revenue pocket for the Fabry disease treatment market over the estimated timeline. The regional market growth is driven by the growing emphasis on healthcare infrastructure expansion projects.
Partial Table of Contents (ToC) of the report:
Chapter 4 Fabry Disease Treatment Market, By Treatment Type
4.1 Key segment trends
4.2 Enzyme Replacement Therapy (ERT)
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.2 By Drug Type
4.2.2.1 Agalsidase Alpa
4.2.2.1.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.2.2 Agalsidase Beta
4.2.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.3 By End-use
4.2.3.1 Physician office
4.2.3.1.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.3.2 Home settings
4.2.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Chaperone Therapy
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/fabry-disease-treatment-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: +1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email: [email protected]